Radiolabelling rituximab with (99m)Tc in three steps procedure.

about

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.

P2860

Q38716531-CDD6606B-4C66-42D5-B1C1-17A92BBA37B7 Q38795442-0463FB3A-AF20-401B-AE17-4D3121532EA0

P2860

Radiolabelling rituximab with (99m)Tc in three steps procedure.

Item

http://www.wikidata.org/entity/Q38870324

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Radiolabelling rituximab with (99m)Tc in three steps procedure.

@en

type

Item

label

Radiolabelling rituximab with (99m)Tc in three steps procedure.

@en

prefLabel

Radiolabelling rituximab with (99m)Tc in three steps procedure.

@en

P1476

Radiolabelling rituximab with (99m)Tc in three steps procedure.

@en

P2093

Anne Sophie Salabert

http://www.w3.org/2001/XMLSchema#string

Charlotte Fontan

http://www.w3.org/2001/XMLSchema#string

Christine Bezombes

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Fournie

http://www.w3.org/2001/XMLSchema#string

Julien Costes

http://www.w3.org/2001/XMLSchema#string

Mathieu Tafani

http://www.w3.org/2001/XMLSchema#string

Raphael Lopez

http://www.w3.org/2001/XMLSchema#string

Yvon Coulais

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.

The role of coordination chemistry in the development of target-specific radiopharmaceuticals.

In vivo imaging in cancer.

Radiolabeling of rituximab with (188)Re and (99m)Tc using the tricarbonyl technology.

(99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent.

Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.

Syntheses, structural characterization and CO releasing properties of boranocarbonate [H3BCO2H]- derivatives.

Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

Whole-animal imaging: The whole picture.

P304

274-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JLCR.3283

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Herve Avet-Loiseau

Pierre Payoux

P577

2015-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26017396

http://www.w3.org/2001/XMLSchema#string

Radiolabelling rituximab with (99m)Tc in three steps procedure.

about

P2860

P2860

Radiolabelling rituximab with (99m)Tc in three steps procedure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698